Neuroject ApS: Financial statements 2023
CVR: 43712241
Source: annual report 2023, Danish Business Authority
16/12/2022 – 31/12/2023
Neuroject ApS (CVR 43712241) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -25,158 and a net result of DKK -32,693. Equity in the 2023 report amounted to DKK 7,307. The solvency ratio was 15.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -25,158
- Profit/Loss
- DKK -32,693
- Equity
- DKK 7,307
- Total Assets
- DKK 48,047
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Neuroject ApS
Neuroject ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2022. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Brian Taammoli. The company is owned by Neural Stem Cell ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 326,576 and a net result of DKK -346,903 compared with DKK 67,834 the year before. Equity in the 2025 report amounted to DKK -271,762.